Trial Profile
A Phase II first-line study of Carboplatin plus Pemetrexed in elderly patients with advanced non-small, non-squamous cell lung cancer
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 03 Apr 2014
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 03 Apr 2014 New trial record